PNC Financial Services Group’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.5K Buy
+6,066
New +$45.7K ﹤0.01% 4113
2023
Q1
– Hold
0
– -$22 – 4819
2022
Q4
– Sell
-125
Closed -$27.5K – 4740
2022
Q3
$34K Hold
125
– – ﹤0.01% 3188
2022
Q2
$60K Hold
125
– – ﹤0.01% 2875
2022
Q1
$162K Hold
125
– – ﹤0.01% 2406
2021
Q4
$208K Buy
125
+81
+184% +$182K ﹤0.01% 2231
2021
Q3
$124K Buy
+44
New +$115K ﹤0.01% 2494
2014
Q4
– Hold
0
– -$2K – 4251
2014
Q3
– Hold
0
– – – 3695

Other funds holding TENX

PNC Financial Services Group's TENX Position: Q3 2026 in Review

PNC Financial Services Group opened a new position in Tenax Therapeutics (TENX) in Q3 2026: 6,066 shares worth $11.5K. The stake represents ﹤0.01% of the portfolio and ranks #4113 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in TENX as recently as Q3 2022.

PNC Financial Services Group first reported a position in TENX in Q3 2021 and has held it in 6 quarters since. The position peaked at $208K in Q4 2021. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

  • PNC Financial Services Group held 6,066 shares of Tenax Therapeutics worth $11.5K as of Q3 2026.
  • Tenax Therapeutics was a new PNC Financial Services Group position in Q3 2026.
  • Tenax Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4113 holding.
  • PNC Financial Services Group first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • PNC Financial Services Group's Tenax Therapeutics position peaked at $208K in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.